Results

Total Results: 1,540 records

Showing results for "month".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
    January 01, 2023 - Design Appendix H. Key Question 2 Predictors Table H-1. KQ2 Predictors of Treatment Efficacy PMID First Author Publication Year Extractor Study Name/Database/RCT PMID/Site Followup Duration N Mean Age (SD) Baseline CY-BOCS Score, Mean (SD) Intervention Type Pharmacolgical Interventions, Drug Class (e.g., SSRI) Phar…
  2. effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
    February 01, 2016 - be associated with small, statistically nonsignificant effects vs. sham manipulation on pain at 1 month … pain relief at 1 week (3 trials; WMD, 0.06 on a 0 to 10 scale; 95% CI, −0.53 to 0.65; I2 = 0%), 1 month … 95% CI, −0.73 to −0.10; I2 = 18%) vs. exercise or advice alone, but there were no differences at 1 month … pain relief at 1 week (3 trials; WMD, 0.06 on a 0 to 10 scale; 95% CI, −0.53 to 0.65; I2 = 0%), 1 month … Combination therapy was also associated with better function at 1 month, (2 trials; SMD, −0.40; 95%
  3. effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - on nonpharmacologic interventions for chronic pain,5 which included studies with greater than 1 month
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
    January 30, 2014 - longitudinal$survey$of$soldiers$in$three$Brigade$Combat$Teams$was$conducted$1"2$months$prior$to$an$average$10"month
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
    January 01, 2017 - As discussed above, both groups showed improvement in AHI at 6-month followup, with maintenance at … 12-month followup (no significant group differences). … collected quality of life data, which were not markedly different between any of the study arms at the 24-month … fewer missed days in tonsillectomy arms vs. no surgery in 2 RCTs with medium study limitations at 12 month
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
    January 01, 2007 - This 12-month study did not report any differences in harms between etanercept and infliximab. … comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
    August 01, 2018 - Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication … A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic … A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed … A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients
  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - Layout 1 Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen of the renal artery. Atherosclerosis accounts for 90 percent of cases of RAS. Atherosclerotic RAS (ARAS) is a progressive disease that may occur alone or in combination with hypertension and ischemic kidney disease. The prevalenc…
  9. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - frequently reported high intervention tolerance and acceptability.13,18 A 2013 Swiss study reported 3-month … measured by a decrease in number of patients reporting a binge-drinking event (baseline: 75.5%; 3-month … message intervention to reduce binge drinking in young adults: a randomized controlled trial with 9-month
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 Literature Update Period: September 2019 through September 2021 Background and Purpose This is the first update for the…
  11. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
    September 26, 2014 - HbA1c is a measure of the average amount of glucose in a patient’s blood over a 3- or 4-month period … The incidence of incisional glaucoma surgery at month 36 was 4.8% in the low-dose group and 8.1% … The mean improvement in BCVA letter score between baseline and month 24 was 4.4 and 5.4 in the low- … These 24-month data were submitted in the manufacturer’s original 2010 FDA NDA. … The 36-month trial results were provided to FDA in May 2011.
  12. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
    March 01, 2022 - pain 2018 AHRQ review: some nonpharmacologic treatments for chronic pain associated with sustained (>1 month
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening for and Management of Chronic Kidney Disease Stages 1-3 I. Background and Objectives for the Systematic Review T…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
    October 11, 2019 - For re- exacerbation, we extracted at the end of intervention, 1-month, 3 month, 6-month, 12-month, … within the first few days after hospital discharge, with a time-related reduction in risk over a 12 month
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
    September 10, 2012 - Disposition of Comments Report for Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1251 Published Online: September 10, 2012 Comparativ…
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - retention requiring an indwelling catheter or clean intermittent catheterization for at least 1 month … of the microwave therapy patients and 22 percent of the TURP patients experienced a UTI over the 6-month … addressed one comparison relevant to our review, immediate implant versus a delayed implant (i.e., 6-month … Gallien, et al. report the rate of UTI at 6 month followup to be 35 percent in the botulinum patients
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
    October 01, 2011 - celecoxib was superior to diclofenac or ibuprofen for ulcer complications or symptomatic ulcers at 6 month … There was no difference in rates of ulcer complications or symptomatic ulcers at either 6 month or … celecoxib was superior to diclofenac or ibuprofen for ulcer complications or symptomatic ulcers at 6 month … However, CLASS found no difference in rates of ulcer complications alone at either 6 month or complete … chondroitin sulphate was associated with a steady improvement in Lequesne ISK scores over the 3- month
  18. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - Twice a month, the project staff will meet to discuss the results and progress to date; review cases
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - Twice a month, the project staff will meet to discuss the results and progress to date; review cases
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
    July 01, 2012 - Invasive Breast Cancer Subject took medication for 5 years with median 81 month follow-up reported … Incidence rates/risks of gynecologic conditions Median 81 month follow- up reported Good/Good … Invasive Breast Cancer Subject took medication for 5 years with median 81 month follow-up reported

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: